Lipidem

Omega-3-Acid Triglycerides, the active ingredient in Lipidem, is an Omega-3 fatty acid supplement presented as an intravenous lipid emulsion for intravenous use. It provides essential fatty acids and calories for patients requiring parenteral nutrition, helping prevent deficiency and support energy needs.

GNH USA supplies Lipidem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology units and pharmacy chains worldwide, ensuring regulatory‑approved quality and reliable cold‑chain logistics for parenteral nutrition products. The company adheres to EU GMP standards and provides comprehensive technical support to clinical teams.

Lipidem, an intravenous omega‑3 fatty acid lipid emulsion, is used in parenteral nutrition to address essential fatty acid deficiency and provide caloric support. - Parenteral nutrition: supplies calories and essential fatty acids for patients unable to receive enteral feeding. - Essential fatty acid deficiency prevention: restores omega‑3 and omega‑6 fatty acid levels in patients on long‑term lipid‑free nutrition. - Caloric supplementation: delivers high‑energy triglycerides to support metabolic demands in critically ill or postoperative patients.

Lipidem may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Hypertriglyceridemia: elevated blood triglyceride levels. - Fever or chills: transient temperature rise after infusion. - Phlebitis: irritation at the infusion site. - Lipemia: milky appearance of plasma.

Serious or Rare Side Effects: - Fat overload syndrome: hepatic dysfunction due to excessive lipid load. - Anaphylactoid reaction: severe hypersensitivity with respiratory distress. - Coagulopathy: impaired clotting due to high omega‑3 content.

When using Lipidem, clinicians should observe specific precautions to ensure patient safety and product integrity. - Patient assessment: evaluate baseline triglyceride levels and liver function before initiation. - Monitoring: check serum triglycerides and liver enzymes regularly during therapy. - Compatibility: avoid mixing with incompatible IV solutions such as calcium‑containing admixtures. - Infusion rate: administer at recommended rate to reduce risk of hypertriglyceridemia and fat overload. - Special populations: use caution in neonates, patients with pancreatitis, or severe hyperlipidaemia. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lipidem can interact with certain medications and nutritional components, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk due to omega‑3 antiplatelet effect. - Propofol infusion: additive lipid load may precipitate hypertriglyceridemia. - High‑dose vitamin E supplements: synergistic anticoagulant effect increasing hemorrhage risk.

Moderate Interactions (Monitor Closely): - Other parenteral lipid emulsions: cumulative lipid intake may exceed safe limits. - Immunosuppressants (e.g., cyclosporine): potential alteration of lipid metabolism. - Diuretics (e.g., furosemide): may affect electrolyte balance when combined with high‑fat infusions.